Vukalovic I

Psychiatric University Hospital, University of Basel, Basel, Switzerland.

4 papers · ORCID

ArticleMDMA

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

Humbert-Droz M, Becker AM, Valenta J +6

Europe PMC2026
ArticlePsilocybin

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Arikci D, Borgulya J, Straumann I +8

Europe PMC2026
ArticleDMT

Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants.

Erne L, Mueller L, Straumann I +7

Europe PMC2026
ArticleMDMA

Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants.

Straumann I, Vizeli P, Avedisian I +7

Europe PMC2026